Decreasing COVID-19 Severity in Older Adults
CFL is committed to staying connected with you and, together, we will navigate these unprecedented times. Here is this week’s featured information to let you know some of the steps we are taking to help prevent and protect our seniors and other high-risk individuals from getting the COVID-19 virus.
During the COVID-19 pandemic, older adults have been among the most impacted groups. People over the age of 65 are particularly vulnerable, developing more severe disease, worse outcomes, and a nearly 100-fold increased risk of dying when compared to younger individuals. UConn Center on Aging at UConn Health will be leading an NIH-funded clinical trial in collaboration with the Marcus Institute for Aging Research at Harvard Medical School and resTORbio. This study is looking at a novel approach to COVID-19 by using medications designed to overcome aging-related declines in immune responses.
Those that may be eligible and interested can contact the study coordinator, Lisa Kenyon-Pesce at [email protected] or (860) 679-2305.
Learn More: Click Here